Category
Primary
pharmaceutical-drugs · embed-ft 0.48
Tree path
Medical Health › Pharmaceutical Drugs
Group (tier-1)
Tech stack
AI readiness
Compliance (GEO / GDPR)
TLD
Overview
Title
KOSELUGO® (selumetinib) | Official Patient Website
Description
Koselugo is used to treat adults and children 1 year of age and older with neurofibromatosis type 1 who have plexiform neurofibromas that cause symptoms and cannot be completely removed by surgery. Please see Patient Information and Instructions for Use in the full Prescribing Information.
Final URL
Language
en (html)
Scanned at
2026-06-23 22:44:33